Mesa, A, Puig-Jov , C, Pan , A, Vinagre, I, L pez-Quesada, E, Meler, E, Alonso-Carril, N, Quir s, C, Amor, A, Perea, V. Pre-eclampsia is an independent predictor of atherosclerosis progression in women with type 1 diabetes: a 5 year prospective study. DIABETOLOGIA. 2025; 68DOI:. PMID:. IF:10.200(Q1/1D).

Vi als, C, Conget, I, Granados, M, Sol , C, Mesa, A, Ser s-Noriega, T, Perea, V, Blanco, J, Vinagre, I, Gim nez, M, Amor, A. Impact of cardiovascular risk factors control on atherosclerosis progression in individuals with type 1 diabetes. DIABETOLOGIA. 2025; 68DOI:. PMID:. IF:10.200(Q1/1D).

Mangas, N, Abraldes, N, Martínez, MJ, Figueroa, D, Ramos, M, López, A, Martínez, C, Pujol, I, Mauricio, D, Corcoy, R. INITIATING GLUCOSE MONITORING IN PERSONS WITH TYPE 2 DIABETES MELLITUS. A RANDOMIZED CONTROL TRIAL COMPARING FSL2 VS. CAPILLARY BLOOD GLUCOSE IN TERMS OF TREATMENT SATISFACTION. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).

Paldánius, PM, Cos, X, Lazaro-Pancheco, D, Salter, J, Mauricio, D. NON-INVASIVE NEAR-INFRARED SYSTEM FOR SCREENING FOR DIABETES: THE RESULTS FROM ANODE03. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).

Paldánius, PM, Salter, J, Hernandez, ME, Tipo, B, Franch, J, Cos, X, Mauricio, D. ASSESSING IMPLEMENTATION OF NOVEL DIABETES SCREENING METHODS ACROSS DIFFERENT CARE DELIVERY SETTINGS. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).

Paldánius, PM, Salter, J, Choudhary, P, Cos, X, Mauricio, D. BENEFIT:RISK ASSESSMENT OF A NOVEL NON-INVASIVE SCREENING TOOL: INSIGHTS FROM THE ANODE CLINICAL PROGRAMME. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).